23-Jan-2026
UBS Sticks to Its Buy Rating for Koninklijke Philips N.V. (0LNG)
TipRanks (Thu, 22-Jan 4:27 AM ET)
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
Globe Newswire (Wed, 21-Jan 5:00 AM ET)
Heartstream Launched as Independent Emergency Care Company
PRNewswire (Wed, 14-Jan 11:04 AM ET)
Business Wire (Wed, 14-Jan 10:31 AM ET)
Globe Newswire (Mon, 15-Dec 2:00 AM ET)
Philips Maintains 2026 Guidance Timeline as Sequential Growth Remains on Track
Market Chameleon (Thu, 4-Dec 5:15 AM ET)
Philips reiterates timing of 2026 outlook
Globe Newswire (Thu, 4-Dec 7:14 AM ET)
Globe Newswire (Mon, 1-Dec 8:00 AM ET)
Globe Newswire (Sun, 30-Nov 12:00 PM ET)
Philips unveils BlueSeal Horizon, industry's first helium-free 3.0T MRI platform
Globe Newswire (Sun, 30-Nov 11:40 AM ET)
Koninklijke Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. Nearly 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, and image-guided therapy solutions. The connected care segment (under 30% of revenue) encompasses monitoring and analytics systems for hospitals, informatics business, and also houses the sleep and respiratory care segment. Personal health business (remainder of revenue) is mainly oral health and personal care product lines, which include electric toothbrushes and men's grooming and personal-care products.
Koninklijke Philips N.V. Ny Registry Shares trades on the NYSE stock market under the symbol PHG.
As of January 23, 2026, PHG stock price declined to $29.40 with 617,291 million shares trading.
PHG has a beta of 1.15, meaning it tends to be more sensitive to market movements. PHG has a correlation of 0.42 to the broad based SPY ETF.
PHG has a market cap of $27.95 billion. This is considered a Large Cap stock.
Last quarter Koninklijke Philips N.V. Ny Registry Shares reported $5 billion in Revenue and $.37 earnings per share. This met revenue expectation and met earnings estimates .
In the last 3 years, PHG traded as high as $32.91 and as low as $15.63.
The top ETF exchange traded funds that PHG belongs to (by Net Assets): DFIV, DFIC, DFAI, AVDE, BINV.
PHG has underperformed the market in the last year with a return of +13.0%, while the SPY ETF gained +14.2%. In the last 3 month period, PHG fell short of the market, returning +1.3%, while SPY returned +2.9%. However, in the most recent 2 weeks PHG has outperformed the stock market by returning -0.6%, while SPY returned -0.7%.
PHG support price is $29.29 and resistance is $30.19 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHG shares will trade within this expected range on the day.